Neutral
No significant market-moving news for SMI20 in the past 24 hours.
Over the past 24 hours, there have been no significant developments affecting the SMI20 index. The most recent notable event was the ordinary index review announced on July 8, 2026, which will take effect on September 21, 2026. This review includes the admission of Galderma Group N and Sandoz Group N to the SMI® and SPI®20 indices, and the exclusion of Swisscom N and Kuehne+Nagel International N.
Key points
- No significant market-moving news for SMI20 in the past 24 hours.
- The most recent notable event was the ordinary index review announced on July 8, 2026.
- The review will take effect on September 21, 2026.
- Changes include the admission of Galderma Group N and Sandoz Group N, and the exclusion of Swisscom N and Kuehne+Nagel International N.
Sources
AI-generated from public news sources. Not financial advice.